Gainor, Justin F <br/><br/>
ALK rearrangements are mutually exclusive with mutations in EGFR or KRAS: an analysis of 1,683 patients with non-small cell lung cancer.  [electronic resource] 

 -  Clinical cancer research : an official journal of the American Association for Cancer Research  Aug 2013 
 - 4273-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1557-3265 
<br/><br/><label>Standard No.: </label>10.1158/1078-0432.CCR-13-0318  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anaplastic Lymphoma Kinase<br/>Carcinoma, Non-Small-Cell Lung--drug therapy<br/>Crizotinib<br/>Drug Resistance, Neoplasm--genetics<br/>ErbB Receptors--genetics<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Gene Rearrangement<br/>Humans<br/>Immunohistochemistry<br/>In Situ Hybridization, Fluorescence<br/>Male<br/>Middle Aged<br/>Mutation<br/>Protein Kinase Inhibitors--administration & dosage<br/>Proto-Oncogene Proteins--genetics<br/>Proto-Oncogene Proteins p21(ras)<br/>Pyrazoles--administration & dosage<br/>Pyridines--administration & dosage<br/>Receptor Protein-Tyrosine Kinases<br/>ras Proteins--genetics